obesity

Scientific research has shown a direct link between night work and cardiovascular disease and cancer More and more people are forced to work night shifts, sacrificing their circadian rhythm for work needs. But what are the consequences of…

Serious side effects raise safety questions for new weight-loss drugs In recent years, glucagon-like peptide-1 receptor agonists (GLP-1), such as semaglutide and liraglutide (marketed respectively as Wegovy and Ozempic), have…

The pharmaceutical company Eli Lilly has launched single dose vials of Zepbound, a cheaper version of tirzepatide The battle against obesity has taken a significant step forward with the introduction of a new, cheaper version of…

New study presents a tool to determine the need for coronary angioplasty through AI The battle against obesity may have found a new ally. Amicretina, an experimental pill developed by Novo Nordisk, has shown promising results in a phase I…